In Vitro and In Vivo Efficacy of a Stroma-Targeted, Tumor Microenvironment Responsive Oncolytic Adenovirus in Different Preclinical Models of Cancer.

Interestingly, a suboptimal dose of AR2011 combined with an optimal dose of cisplatin significantly increased mice survival compared to any other group, although it did not reach statistical significance with the group of mice treated with cisplatin alone ( p = 0.1791 ( Figure 2 C). 2.2.

also in 111,027 other papers